Print

This retrospective, observational, multi-center study will evaluate the use of biological agents (e.g. RoActemra/Actemra [tocilizumab]) in monotherapy in patients with rheumatoid arthritis. Data from medical record files will be collected of patients currently treated with a biologic in monotherapy.

Read more: http://www.clinicaltrials.gov/ct2/show/NCT01834807?cond=%22Arthritis%22&lup_s=01/29/2014&lup_d=30